Know Labs Inc., a Nevada corporation, entered into a Promissory Note Conversion Agreement with J3E2A2Z LP, an entity affiliated with CEO Ronald P. Erickson, on June 2, 2025. J3E2A2Z agreed to exchange approximately $1.18 million in aggregate principal for shares of Know Labs' newly designed class of convertible preferred stock. The Series H Preferred Stock features a conversion price of $0.50 per share, with price-based, "full-ratchet," and proportional anti-dilution rights. Further details on the number of shares were not disclosed in the document.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.